Alcoholic macrocytosis - Is there a role for acetaldehyde and adducts?

Addiction Biology

Volumn 9, Issue 1, 2004, Pages 3-10

  Niemelä, Onni ^a,b   Parkkila, Seppo ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

^b EP Central Hospital Laboratory   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL;

ALCOHOL ABUSE; ALCOHOLISM; BONE MARROW CELL; CELL FUNCTION; DATA ANALYSIS; ERYTHROCYTE; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HUMAN; MEGALOCYTOSIS; METABOLITE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW;

ACETALDEHYDE; ALCOHOLISM; BONE MARROW; ERYTHROCYTE INDICES; ERYTHROCYTES; HEMATOLOGIC DISEASES; HEMATOPOIESIS; HUMANS;

EID: 2342464852     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210410001674031     Document Type: Review

References (85)

1. Lindenbaum J. Haematologic complications of alcohol abuse. Semin Liver Dis 1987;7:169-81.
2. Latvala J, Parkkila S, Niemelä O. Effects of ethanol consumption on blood and bone marrow cells. Submitted for publication.
3. Wymer A, Becker DM. Recognition and evaluation of red blood cell macrocytosis in the primary care setting. J Gen Intern Med 1990;5:192-7.
4. Savage DG, Ogundibe A, Allen RH, Stabler SP, Lindenbaum J. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci 2000;319:343-52.
5. Seppä K, Laippala P, Saarni, M. Macrocytosis as a consequence of alcohol abuse among patients in general practice. Alcohol Clin Exp Res 1991;15:871-6.
6. Lindenbaum J. Metabolic effects of alcohol on the blood and bone marrow. In: Lieber CS, editor. Metabolic aspects of alcoholism. Baltimore: University Park Press, 1977:215-47.
7. Maruyama S, Hirayama C, Yamamoto S, et al. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 2001;138:332-7.
8. Wu A, Chanarin I, Levi AJ. Macrocytosis of chronic alcoholism. Lancet. 1974;4:829-31.
9. Morgan MY, Camilo ME, Luck W, Sherlock S, Hoffbrand AV. Macrocytosis in alcohol-related liver disease: its value for screening. Clin Lab Haematol 1981;3:35-44.
10. Sillanaukee, P. Laboratory markers of alcohol abuse. Alcohol Alcohol 1996;6:613-16.
11. Niemelä O. Serum diagnosis of ALD and markers of ethanol intake. In: Ethanol and the liver: mechanisms and management. Sherman D, Preedy V, Watson R, editors. London: Taylor and Francis Academic Publishers, 2002;411-49.
12. Michot F, Gut J. Alcohol-induced bone marrow damage. A bone marrow study in alcohol-dependent individuals. Acta Haematol 1978;78:252-7.
13. Meagher RC, Sieber F, Spivak JL. Suppression of haematopoietic- progenitor-cell proliferation by ethanol and acetaldehyde. N Engl J Med 1982;30:845-9.
14. Levine RF, Spivak JL, Meagher RC, Sieber F. Effect of ethanol on thrombosis. Br J Haematol 1986;62:345-54.
15. Beauge F, Gallay J, Stibler H, Borg S. Alcohol abuse increases the lipid structural order in human erythrocyte membranes. A steady-state and time-resolved anisotrophy study. Biochem Pharmacol 1988;37:3823-8.
16. Wickramasinghe SN, Malik F. Acetaldehyde causes a prolongation of the doubling time and an increase in the modal volume of cells in culture. Alcohol Clin Exp Res 1986;10:350-4.
17. Tyulina OV, Prokopieva VD, Dodd RD, et al. In vitro effects of ethanol, acetaldehyde and fatty acid ethyl esters on human erythrocytes. Alcohol Alcohol 2002;37:179-86.
18. Hernández-Muños R, Baraona E, Blacksberg I, Lieber CS. Characterization of the increased binding of acetaldehyde to red blood cells in alcoholics. Alcohol Clin Exp Res 1989;13:654-9.
19. Magnani M, Laguerre M, Rosa L, et al. In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. Alcohol Alcohol 1990;25:627-37.
20. Hazelett SE, Liebelt RA, Brown WJ, Androulakakis V, Jarjoura D, Truitt EB Jr. Evaluation of acetaldehyde-modified hemoglobin and other markers of chronic heavy alcohol use: effects of gender and hemoglobin concentration. Alcohol Clin Exp Res 1998;22:1811-19.
21. Takeshita M, Morimoto K. Accumulation of hemoglobin-associated acetaldehyde with habitual alcohol drinking in the atypical ALDH2 genotype. Alcohol Clin Exp Res 2000;24:1-7.
22. Latvala J, Parkkila S, Melkko J, Niemelä O. Acetaldehyde adducts in blood and bone marrow of patients with ethanol-induced erythrocyte abnormalities. Mol Med 2001;7:401-5.
23. Eriksson CJ. The role of acetaldehyde in the actions of alcohol. Alcohol Clin Exp Res 2001;25:S15-32.
24. Peterson CM, Jovanovic-Peterson L, Schmid-Formby F. Rapid association of acetaldehyde with hemoglobin in human volunteers after low dose ethanol. Alcohol 1988;5:371-4.
25. Gaines KC, Salhany JM, Tuma DJ, Sorrell MF. Reaction of acetaldehyde with human erythrocyte membrane proteins. FEBS Letters, 1979;75:115-19.
26. Niemelä O, Israel Y. Hemoglobin-acetaldehyde adducts in human alcohol abusers. Lab Invest 1992;67:246-52.
27. Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995;333:1058-65.
28. Tuma DJ, Klassen LW. Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. Gastroenterology 1992;103:1969-73.
29. Niemelä O. Acetaldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Front Biosci 1999;4:D506-13.
30. Stevens VJ, Fand WJ, Newman CB, Sims RV, Cerami A, Peterson CM. Acetaldehyde adducts with hemoglobin. J Clin Invest 1981;67:361-9.
31. Israel Y, Hurwitz E, Niemelä O, Arnon R. Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 1986;83:7923-7.
32. Sorrell MF, Tuma DJ. The functional implications of acetaldehyde binding to cell constituents. Ann NY Acad Sci, 1987;492:50-62.
33. Nicholls R, de Jersey J, Worrall S, Wilce P. Modification of proteins and other biological molecules by acetaldehyde: adduct structure and functional significance. Int J Biochem 1992;24:1899-906.
34. 14C] acetaldehyde to serum albumin. Arch Biochem 1983;220:239-46.
35. San George RC, Hoberman HD. Reaction of acetaldehyde with hemoglobin. J Biol Chem 1986;261:6811-21.
36. Jennett RB, Sorrell MF, Saffari-Fard A, Ockner JL, Tuma DJ. Preferential covalent binding of acetaldehyde to the α-chain of purified rat liver tubulin. Hepatology 1989;9:57-62.
37. Tuma DJ, Newman MR, Donohue TM, Sorrell MF. Covalent binding of acetaldehyde to proteins: participation of lysine residues. Alcohol Clin Exp Res 1987;11:579-84.
38. Klassen LW, Tuma DJ, Sorrell MF, McDonald TL, DeVasure JM, Thiele GM. Detection of reduced acetaldehyde protein adducts using a unique monoclonal antibody. Alcohol Clin Exp Res 1994;18:164-71.
39. Braun KP, Cody RB, Jones DR, Peterson CM. A structural assignment for a stable acetaldehyde-lysine adduct. J Biol Chem 1995;270:11263-6.
40. Fowles LF, Beck E, Worrall S, Shanley BC, de Jersey J. The formation and stability of imidazolidinone adducts from acetaldehyde and model peptides. A kinetic study with implications for protein modification in alcohol abuse. Biochem Pharmacol 1996;51:1259-67.
41. Braun KP, Pavlovich JG, Jones DR, Peterson CM. Stable acetaldehyde adducts: structural characterization of acetaldehyde adducts of human hemoglobin N-terminal beta-globin chain peptides. Alcohol Clin Exp Res 1997;21:40-3.
42. Lin RC, Shahidi S, Lumeng L. Production of antibodies that recognize the heterogeneity of immunoreactive sites in human hemoglobin chemically modified by acetaldehyde. Alcohol Clin Exp Res 1993;17:882-6.
43. Eriksson CJP, Fukunaga T. Human blood acetaldehyde (updated 1992). Alcohol Alcohol 1993;Suppl 2:9-25.
44. Nuutinen H, Lindros KO, Salaspuro M. Determinants of blood acetaldehyde level during ethanol oxidation in chronic alcoholics. Alcohol Clin Exp Res 1983;7:163-8.
45. Niemelä O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Rad Biol Med 2001;31:1533-8.
46. Tuma DJ, Thiele GM, Xu D, Klassen LW, Sorrell MF. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 1996;23:872-80.
47. French SW, Wong K, Jui L, Albano E, Hagbjörk A-L, Ingelman-Sundberg M. Effect of ethanol on cytochrome P450 (CYP2E1), lipid peroxidation and serum protein adduct formation in relation to liver pathology. Exp Mol Pathol 1993;58:61-75.
48. Wickramasinghe SN, Gardner B, Barden G. Cytotoxic protein molecules generated as a consequence of ethanol metabolism in vitro and in vivo. Lancet 1986;ii:823-6.
49. Peterson CM, Polizzi CM. Improved method for acetaldehyde in plasma and hemoglobin-associated acetaldehyde: results in teetotalers and alcoholics reporting for treatment. Alcohol 1987;4:477-80.
50. Lin RC, Lumeng L, Shahidi S, Kelly T, Pound DC. Protein-acetaldehyde adducts in serum of alcoholic patients. Alcohol Clin Exp Res 1990;14:438-43.
51. Niemelä O, Parkkila S, Ylä-Herttuala S, et al. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 1994;70:537-46.
52. Steinbrecher UP, Fisher M, Witztum JL, Curtiss LK. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for the derivatized lysine. J Lipid Res 1984;25:1109-16.
53. Savolainen MJ, Baraona E, Lieber CS. Acetaldehyde binding increases the catabolism of rat serum low-density lipoprotein. Life Sci 1987;40:841-6.
54. Wehr H, Rodo M, Lieber CS, Baraona E. Acetaldehyde adducts and autoantibodles against VLDL and LDL in alcoholics. J Lipid Res 1993;34:1237-44.
55. Latvala J, Melkko J, Parkkila S, Järvi K, Makkonen K, Niemelä O. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde-lipoprotein condensates. Alcohol Clin Exp Res 2001;25:1648-53.
56. Lin RC, Dai J, Lumeng L, Zhang M. Serum low density lipoprotein of alcoholic patients is chemically modified in vivo and induces apolipoprotein E synthesis by macrophages. J Clin Invest 1995;95:1979-86.
57. Niemelä O, Juvonen T, Parkkila S. Immunohistochemical demonstration of acetaldehyde modified epitopes in human liver after alcohol consumption. J Clin Invest 1991;87:1367-74.
58. Tsukamoto H, Home W, Kamimura S, et al. Experimental liver disease induced by alcohol and iron. J Clin Invest 1995;96:620-30.
59. Niemelä O, Parkkila S, Ylä-Herttuala S, Villanueva J, Ruebner B, Halsted C. Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol induced liver disease. Hepatology 1995;22:1208-14.
60. Halsted CH, Villanueva JA, Devlin AM, et al. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc Natl Acad Sci USA 2002;99:10072-7.
61. Smith SL, Jennett RB, Sorrell MF, Tuma DJ. Acetaldehyde substoichiometrically inhibits bovine neurotubulin polymerization. J Clin Invest 1989;84:337-41.
62. Mauch TJ, Donohue TM, Zettermann RK, Sorrell MF, Tuma DJ. Covalent binding of acetaldehyde selectively inhibits the catalytic activity of lysine dependent enzymes. Hepatology 1986;6:263-9.
63. McKinnon G, de Jersey J, Shanley B, Ward L. The reaction of acetaldehyde with brain microtubular proteins: formation of stable adducts and inhibition of polymerization. Neurosci Lett 1987;79:163-8.
64. Mauch TJ, Tuma DJ, Sorrell MF. The binding of acetaldehyde to the active site of ribonuclease: alterations in catalytic activity and effects of phosphate. Alcohol 1987;22:103-12.
65. Pares A, Potter JJ, Rennie L, Mezey E. Acetaldehyde activates the promoter of the mouse α2(I) collagen gene. Hepatology 1994;19:498-503.
66. Brenner DA, Chojkier M. Acetaldehyde increases collagen gene transcription in cultured human fibroblasts. J Biol Chem 1987;262:17690-5.
67. Casini A, Cunningham M, Rojkind M, Lieber CS. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991;13:758-65.
68. Viitala K, Blake JE, Israel Y, Niemelä O. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption. Hepatology 1997;25:1418-24.
69. Hoerner M, Behrens UJ, Worner TM, et al. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 1988;8:569-74.
70. Koskinas J, Kenna JG, Bird GL, Alexander GJM, Williams R. Immunoglobulin A antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis. Gastroenterology 1992;103:1860-7.
71. Israel Y, Orrego H, Niemelä O. Immune responses to alcohol metabolites: pathogenic and diagnostic implications. Semin Liver Dis 1988;8:81-90.
72. Izumi N, Sakai Y, Koyama W, Hasumura, Y. Clinical significance of serum antibodies against alcohol-altered hepatocyte membrane in alcoholic liver disease. Alcohol Clin Exp Res 1989;13:762-5.
73. Niemelä O, Klajner F, Orrego H, Vidins E, Blendis L, Israel Y. Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 1987;7:1210-4.
74. Worrall S, de Jersey J, Shanley BC, Wilce PA. Antibodies against acetaldehyde-modified epitopes: an elevated IgA response in alcoholics. Eur J Clin Invest 1991;21:90-5.
75. Viitala K, Makkonen K, Israel Y, et al. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers. Alcohol Clin Exp Res 2000;24:1103-9.
76. Xu D, Thiele GM, Beckenhauer JL, Klassen LW, Sorrell MF, Tuma DJ. Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats. Gastroenterology 1998;115:686-92.
77. Rolla R, Vay D, Mottaran E, et al. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 2000;31:878-84.
78. Niemelä O, Parkkila S, Britton RS, Brunt E, Janney C, Bacon B. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. J Clin Lab Med 1999;133:451-60.
79. Sillanaukee P, Seppä K, Koivula T, Israel Y, Niemelä O. Acetaldehyde-modified hemoglobin as a marker of alcohol consumption: comparison of two new methods. J Lab Clin Med 1992;120:42-7.
80. Chen HM, Scott BK, Braun KP, Peterson CM. Validated fluorimetric HPLC analysis of acetaldehyde in hemoglobin fractions separated by cation exchange chromatography: three new peaks associated with acetaldehyde. Alcohol Clin Exp Res 1995;19:939-44.
81. Gross MD, Gapstur SM, Belcher JD, Scarlan G, Potter JD. The identification and partial characterization of acetaldehyde adducts of hemoglobin occurring in vivo: a possible marker of alcohol consumption. Alcohol Clin Exp Res 1992;16:1093-7.
82. Lin RC, Shahidi S, Kelly TJ, Lumeng C, Lumeng L. Measurement of hemoglobin-acetaldehyde adduct in alcoholic patients. Alcohol Clin Exp Res 1993;17:669-74.
83. Niemelä O, Israel Y, Mizoi Y, Fukunaga T, Eriksson CJP. Hemoglobin-acetaldehyde adducts in human volunteers following acute ethanol ingestion. Alcohol Clin Exp Res 1990;14:838-41.
84. Niemelä O, Halmesmäki E, Ylikorkala O. Hemoglobin-acetaldehyde adducts are elevated in women with alcohol-damaged fetuses. Alcohol Clin Exp Res 1991;15:1007-10.
85. Sarkola T, Eriksson CJP, Niemelä O, Sillanaukee P, Halmesmäki E. Mean cell volume and gamma-glutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobin-acetaldehyde adducts in the follow-up of pregnant women with alcohol abuse. Acta Obstet Gynecol Scand 2000;79:359-66.